Ziegler served as exclusive financial advisor to Essex Management on the sale to Emmes, a global, full-service Clinical Research Organization and portfolio company of New Mountain Capital. Essex’s bioinformatics technology expertise, combined with Emmes’ CRO services, will open doors to new opportunities with a wider set of government agencies and create innovative data strategies for their biopharma clients.